|
Pathway Name (KEGG)
|
% Genes
|
p-value
|
|
Cytokine-cytokine receptor interaction
|
16,0337553
|
1,22E-26
|
|
Complement and coagulation cascades
|
7,59,493,671
|
1,64E-20
|
|
Graft-versus-host disease
|
4,85,232,068
|
1,33E-13
|
|
Allograft rejection
|
4,21,940,928
|
1,28E-10
|
|
Focal adhesion
|
9,28,270,042
|
4,28E-09
|
|
Type I diabetes mellitus
|
4,21,940,928
|
4,58E-09
|
|
Antigen processing and presentation
|
5,69,620,253
|
1,25E-08
|
|
Hematopoietic cell lineage
|
5,48,523,207
|
1,95E-07
|
|
Jak-STAT signaling pathway
|
7,17,299,578
|
1,91E-06
|
|
Renin-angiotensin system
|
2,32,067,511
|
2,63E-05
|
|
TGF-beta signaling pathway
|
4,64,135,021
|
2,13E-04
|
|
Adipocytokine signaling pathway
|
4,00843882
|
2,91E-04
|
|
Endocytosis
|
6,96,202,532
|
5,37E-04
|
|
Natural killer cell mediated cytotoxicity
|
5,69,620,253
|
6,70E-04
|
|
Pathway Name (Reactome)
|
% Genes
|
FDR
|
|
Hemostasis
|
15,8,227,848
|
7,21E-29
|
|
Signaling in Immune system
|
12,2,362,869
|
7,53E-11
|
|
Signaling by PDGF
|
5,06329114
|
1,73E-08
|
|
Signaling by VEGF
|
2,10,970,464
|
2,00E-06
|
|
Integrin cell surface interactions
|
4,85,232,068
|
2,05E-05
|
